These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 13427632)

  • 21. Clinical trial of the new oral hypoglycaemic agent BZ 55.
    HUNT JA; OAKLEY W; LAWRENCE RD
    Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of N-substituted methanedisulfonamides and N'-substituted methanedisulfonylureas.
    KESSLER WV; JENKINS GL
    J Pharm Sci; 1961 Oct; 50():842-4. PubMed ID: 14455414
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolbutamide in diabetes; some clinical and biochemical studies.
    CROWLEY MF; WOLFF FW; BLOOM A
    Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience and experimental studies with tolbutamide.
    CRAIG JW; MILLER M
    Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin adjuvants or substitutes.
    BEST CH
    Can Med Assoc J; 1956 Jun; 74(12):957-9. PubMed ID: 13329940
    [No Abstract]   [Full Text] [Related]  

  • 26. [New substances with effect on blood sugar].
    ZAWACKI F; JUNG F
    Klin Wochenschr; 1957 Apr; 35(7):363-4. PubMed ID: 13429840
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoglycemic sulfonylureas in various types of experimental diabetes.
    BUSE JF; GORDON MF; LUKENS FD
    Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of sulfanilamide-resistant diseases with mixtures of sulfanilamide compounds with urea].
    JUDELES AL; POSTOVSKY IJ
    Klin Med (Mosk); 1947; 25(1):65-9. PubMed ID: 20269445
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action.
    COX RW; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):366-77. PubMed ID: 13365476
    [No Abstract]   [Full Text] [Related]  

  • 30. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
    KRAHL ME; LUKENS FD; RICKETTS HT
    Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
    [No Abstract]   [Full Text] [Related]  

  • 31. [Invenol].
    Med Monatsschr; 1956 Mar; 10(3):200-2. PubMed ID: 13333629
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the mechanism of action of orinase (tolbutamide).
    VAUGHAN M
    Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations in diabetic subjects treated with sulfonylurea compounds.
    BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
    Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on the action of tolbutamide.
    ANDERSON GE; MONACO RN; PERFETTO AJ; TERMINE CM
    Diabetes; 1957; 6(1):34-40; discussion, 43-5. PubMed ID: 13397419
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
    COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
    [No Abstract]   [Full Text] [Related]  

  • 37. The site of action of the arylsulfonylureas in man.
    FROESCH ER; RENOLD AE; THORN GW; WINEGRAD AI
    Diabetes; 1957; 6(1):33; discussion, 43-5. PubMed ID: 13397418
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral antidiabetics].
    DORIA G
    Boll Chim Farm; 1956 Oct; 95(10):427-31. PubMed ID: 13383078
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
    [No Abstract]   [Full Text] [Related]  

  • 40. BZ 55 in diabetes.
    MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
    Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.